Tyrosine Kinase Inhibitors for Metastatic Renal Cell Carcinoma - What Should We Tell Our Patients?. (November 2017) - Cobley, J.; Broadley, G.; Khan, F.; Harvey, K.; Parry, C.; Rajjayabun, P.